Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways
Volume: 71, Pages: 110 - 121
Published: Sep 1, 2019
Abstract
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver-related morbidity and mortality disease in the world. However, no effective pharmacological treatment for NAFLD has been found. In this study, we used a high fat diet (HFD)-induced NAFLD model to investigate hepatoprotective effect of apigenin (API) against NAFLD and further explored its potential mechanism. Our results demonstrated that gavage administration of API...
Paper Details
Title
Apigenin ameliorates HFD-induced NAFLD through regulation of the XO/NLRP3 pathways
Published Date
Sep 1, 2019
Volume
71
Pages
110 - 121
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History